Golab J - Search Results

1

Statins impair glucose uptake in tumor cells.

Malenda A, Skrobanska A, Issat T, Winiarska M, Bil J, Oleszczak B, Sinski M, Firczuk M, Bujnicki JM, Chlebowska J, Staruch AD, Glodkowska-Mrowka E, Kunikowska J, Krolicki L, Szablewski L, Gaciong Z, Koziak K, Jakobisiak M, Golab J, Nowis DA. Malenda A, et al. Among authors: golab j. Neoplasia. 2012 Apr;14(4):311-23. doi: 10.1593/neo.12444. Neoplasia. 2012. PMID: 22577346 Free PMC article. Clinical Trial.

2

Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.

Lasek W, Wańkowicz A, Kuc K, Feleszko W, Gołab J, Giermasz A, Wiktor-Jedrzejczak W, Jakóbisiak M. Lasek W, et al. Among authors: golab j. Cancer Immunol Immunother. 1995 May;40(5):315-21. doi: 10.1007/BF01519632. Cancer Immunol Immunother. 1995. PMID: 7600564 Free PMC article.

3

Synergistic antitumor activity of tumor necrosis factor-alpha and lovastatin against MmB16 melanoma in mice.

Feleszko W, Lasek W, Gołab J, Jakóbisiak M. Feleszko W, et al. Among authors: golab j. Neoplasma. 1995;42(2):69-74. Neoplasma. 1995. PMID: 7617079

4

Potentiation of the anti-tumor effect of actinomycin D by tumor necrosis factor alpha in mice: correlation between in vitro and in vivo results.

Lasek W, Giermasz A, Kuc K, Wańkowicz A, Feleszko W, Gołab J, Zagozdzon R, Stokłosa T, Jakóbisiak M. Lasek W, et al. Among authors: golab j. Int J Cancer. 1996 May 3;66(3):374-9. doi: 10.1002/(SICI)1097-0215(19960503)66:3<374::AID-IJC18>3.0.CO;2-B. Int J Cancer. 1996. PMID: 8621260

5

Antitumor effects of the combination immunotherapy with interleukin-12 and tumor necrosis factor alpha in mice.

Lasek W, Feleszko W, Golab J, Stokłosa T, Marczak M, Dabrowska A, Malejczyk M, Jakóbisiak M. Lasek W, et al. Among authors: golab j. Cancer Immunol Immunother. 1997 Oct;45(2):100-8. doi: 10.1007/s002620050408. Cancer Immunol Immunother. 1997. PMID: 9390201 Free PMC article.

6

Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model.

Zagozdzon R, Stokłosa T, Gołab J, Giermasz A, Dabrowska A, Lasek W, Jakóbisiak M. Zagozdzon R, et al. Among authors: golab j. Anticancer Res. 1997 Nov-Dec;17(6D):4493-8. Anticancer Res. 1997. PMID: 9494557

7

Granulocyte colony-stimulating factor demonstrates antitumor activity in melanoma model in mice.

Gołab J, Zagozdzon R, Stokłosa T, Kaca A, Dabrowska A, Giermasz A, Feleszko W, Jakóbisiak M. Gołab J, et al. Neoplasma. 1998;45(1):35-9. Neoplasma. 1998. PMID: 9605000

8

Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice.

Feleszko W, Zagozdzon R, Gołab J, Jakóbisiak M. Feleszko W, et al. Among authors: golab j. Eur J Cancer. 1998 Feb;34(3):406-11. doi: 10.1016/s0959-8049(97)10034-x. Eur J Cancer. 1998. PMID: 9640231

9

Subtherapeutic doses of interleukin-15 augment the antitumor effect of interleukin-12 in a B16F10 melanoma model in mice.

Lasek W, Golab J, Maśliński W, Switaj T, Bałkowiec EZ, Stokłosa T, Giermasz A, Malejczyk M, Jakóbisiak M. Lasek W, et al. Among authors: golab j. Eur Cytokine Netw. 1999 Sep;10(3):345-56. Eur Cytokine Netw. 1999. PMID: 10477391 Free article.

10

Potentiation of antitumor effects of IL-12 in combination with paclitaxel in murine melanoma model in vivo.

Zagozdzon R, Golab J, Mucha K, Foroncewicz B, Jakobisiak M. Zagozdzon R, et al. Among authors: golab j. Int J Mol Med. 1999 Dec;4(6):645-8. doi: 10.3892/ijmm.4.6.645. Int J Mol Med. 1999. PMID: 10567677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

184 results

Search Page

Filters